Influenza Medication and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Influenza Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Medication Overall Market Size
2.1 Global Influenza Medication Market Size: 2023 VS 2030
2.2 Global Influenza Medication Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Influenza Medication Sales: 2019-2030
3 Company Landscape
3.1 Top Influenza Medication Players in Global Market
3.2 Top Global Influenza Medication Companies Ranked by Revenue
3.3 Global Influenza Medication Revenue by Companies
3.4 Global Influenza Medication Sales by Companies
3.5 Global Influenza Medication Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Influenza Medication Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Influenza Medication Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Medication Players in Global Market
3.8.1 List of Global Tier 1 Influenza Medication Companies
3.8.2 List of Global Tier 2 and Tier 3 Influenza Medication Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Medication Market Size Markets, 2023 & 2030
4.1.2 Zanamivir
4.1.3 Oseltamivir
4.1.4 Peramivir
4.1.5 Amantadine
4.1.6 Rimantadine
4.1.7 Inosine
4.1.8 Others
4.2 By Type - Global Influenza Medication Revenue & Forecasts
4.2.1 By Type - Global Influenza Medication Revenue, 2019-2024
4.2.2 By Type - Global Influenza Medication Revenue, 2025-2030
4.2.3 By Type - Global Influenza Medication Revenue Market Share, 2019-2030
4.3 By Type - Global Influenza Medication Sales & Forecasts
4.3.1 By Type - Global Influenza Medication Sales, 2019-2024
4.3.2 By Type - Global Influenza Medication Sales, 2025-2030
4.3.3 By Type - Global Influenza Medication Sales Market Share, 2019-2030
4.4 By Type - Global Influenza Medication Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Medication Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Pharmacies
5.1.5 Others
5.2 By Application - Global Influenza Medication Revenue & Forecasts
5.2.1 By Application - Global Influenza Medication Revenue, 2019-2024
5.2.2 By Application - Global Influenza Medication Revenue, 2025-2030
5.2.3 By Application - Global Influenza Medication Revenue Market Share, 2019-2030
5.3 By Application - Global Influenza Medication Sales & Forecasts
5.3.1 By Application - Global Influenza Medication Sales, 2019-2024
5.3.2 By Application - Global Influenza Medication Sales, 2025-2030
5.3.3 By Application - Global Influenza Medication Sales Market Share, 2019-2030
5.4 By Application - Global Influenza Medication Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Influenza Medication Market Size, 2023 & 2030
6.2 By Region - Global Influenza Medication Revenue & Forecasts
6.2.1 By Region - Global Influenza Medication Revenue, 2019-2024
6.2.2 By Region - Global Influenza Medication Revenue, 2025-2030
6.2.3 By Region - Global Influenza Medication Revenue Market Share, 2019-2030
6.3 By Region - Global Influenza Medication Sales & Forecasts
6.3.1 By Region - Global Influenza Medication Sales, 2019-2024
6.3.2 By Region - Global Influenza Medication Sales, 2025-2030
6.3.3 By Region - Global Influenza Medication Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Influenza Medication Revenue, 2019-2030
6.4.2 By Country - North America Influenza Medication Sales, 2019-2030
6.4.3 US Influenza Medication Market Size, 2019-2030
6.4.4 Canada Influenza Medication Market Size, 2019-2030
6.4.5 Mexico Influenza Medication Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Influenza Medication Revenue, 2019-2030
6.5.2 By Country - Europe Influenza Medication Sales, 2019-2030
6.5.3 Germany Influenza Medication Market Size, 2019-2030
6.5.4 France Influenza Medication Market Size, 2019-2030
6.5.5 U.K. Influenza Medication Market Size, 2019-2030
6.5.6 Italy Influenza Medication Market Size, 2019-2030
6.5.7 Russia Influenza Medication Market Size, 2019-2030
6.5.8 Nordic Countries Influenza Medication Market Size, 2019-2030
6.5.9 Benelux Influenza Medication Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Influenza Medication Revenue, 2019-2030
6.6.2 By Region - Asia Influenza Medication Sales, 2019-2030
6.6.3 China Influenza Medication Market Size, 2019-2030
6.6.4 Japan Influenza Medication Market Size, 2019-2030
6.6.5 South Korea Influenza Medication Market Size, 2019-2030
6.6.6 Southeast Asia Influenza Medication Market Size, 2019-2030
6.6.7 India Influenza Medication Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Influenza Medication Revenue, 2019-2030
6.7.2 By Country - South America Influenza Medication Sales, 2019-2030
6.7.3 Brazil Influenza Medication Market Size, 2019-2030
6.7.4 Argentina Influenza Medication Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Influenza Medication Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Influenza Medication Sales, 2019-2030
6.8.3 Turkey Influenza Medication Market Size, 2019-2030
6.8.4 Israel Influenza Medication Market Size, 2019-2030
6.8.5 Saudi Arabia Influenza Medication Market Size, 2019-2030
6.8.6 UAE Influenza Medication Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Daiichi Sankyo Company
7.1.1 Daiichi Sankyo Company Company Summary
7.1.2 Daiichi Sankyo Company Business Overview
7.1.3 Daiichi Sankyo Company Influenza Medication Major Product Offerings
7.1.4 Daiichi Sankyo Company Influenza Medication Sales and Revenue in Global (2019-2024)
7.1.5 Daiichi Sankyo Company Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Influenza Medication Major Product Offerings
7.2.4 GlaxoSmithKline Influenza Medication Sales and Revenue in Global (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Natco Pharma
7.3.1 Natco Pharma Company Summary
7.3.2 Natco Pharma Business Overview
7.3.3 Natco Pharma Influenza Medication Major Product Offerings
7.3.4 Natco Pharma Influenza Medication Sales and Revenue in Global (2019-2024)
7.3.5 Natco Pharma Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Influenza Medication Major Product Offerings
7.4.4 F. Hoffmann-La Roche Influenza Medication Sales and Revenue in Global (2019-2024)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Teva Pharmaceutical
7.5.1 Teva Pharmaceutical Company Summary
7.5.2 Teva Pharmaceutical Business Overview
7.5.3 Teva Pharmaceutical Influenza Medication Major Product Offerings
7.5.4 Teva Pharmaceutical Influenza Medication Sales and Revenue in Global (2019-2024)
7.5.5 Teva Pharmaceutical Key News & Latest Developments
7.6 Sandoz International
7.6.1 Sandoz International Company Summary
7.6.2 Sandoz International Business Overview
7.6.3 Sandoz International Influenza Medication Major Product Offerings
7.6.4 Sandoz International Influenza Medication Sales and Revenue in Global (2019-2024)
7.6.5 Sandoz International Key News & Latest Developments
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Company Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Influenza Medication Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Influenza Medication Sales and Revenue in Global (2019-2024)
7.7.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Influenza Medication Major Product Offerings
7.8.4 Mylan Influenza Medication Sales and Revenue in Global (2019-2024)
7.8.5 Mylan Key News & Latest Developments
8 Global Influenza Medication Production Capacity, Analysis
8.1 Global Influenza Medication Production Capacity, 2019-2030
8.2 Influenza Medication Production Capacity of Key Manufacturers in Global Market
8.3 Global Influenza Medication Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Influenza Medication Supply Chain Analysis
10.1 Influenza Medication Industry Value Chain
10.2 Influenza Medication Upstream Market
10.3 Influenza Medication Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Influenza Medication Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Influenza Medication in Global Market
Table 2. Top Influenza Medication Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Influenza Medication Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Influenza Medication Revenue Share by Companies, 2019-2024
Table 5. Global Influenza Medication Sales by Companies, (K Units), 2019-2024
Table 6. Global Influenza Medication Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Influenza Medication Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Influenza Medication Product Type
Table 9. List of Global Tier 1 Influenza Medication Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Medication Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Influenza Medication Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Influenza Medication Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Influenza Medication Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Influenza Medication Sales (K Units), 2019-2024
Table 15. By Type - Global Influenza Medication Sales (K Units), 2025-2030
Table 16. By Application ? Global Influenza Medication Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Influenza Medication Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Influenza Medication Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Influenza Medication Sales (K Units), 2019-2024
Table 20. By Application - Global Influenza Medication Sales (K Units), 2025-2030
Table 21. By Region ? Global Influenza Medication Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Influenza Medication Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Influenza Medication Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Influenza Medication Sales (K Units), 2019-2024
Table 25. By Region - Global Influenza Medication Sales (K Units), 2025-2030
Table 26. By Country - North America Influenza Medication Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Influenza Medication Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Influenza Medication Sales, (K Units), 2019-2024
Table 29. By Country - North America Influenza Medication Sales, (K Units), 2025-2030
Table 30. By Country - Europe Influenza Medication Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Influenza Medication Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Influenza Medication Sales, (K Units), 2019-2024
Table 33. By Country - Europe Influenza Medication Sales, (K Units), 2025-2030
Table 34. By Region - Asia Influenza Medication Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Influenza Medication Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Influenza Medication Sales, (K Units), 2019-2024
Table 37. By Region - Asia Influenza Medication Sales, (K Units), 2025-2030
Table 38. By Country - South America Influenza Medication Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Influenza Medication Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Influenza Medication Sales, (K Units), 2019-2024
Table 41. By Country - South America Influenza Medication Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Influenza Medication Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Influenza Medication Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Influenza Medication Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Influenza Medication Sales, (K Units), 2025-2030
Table 46. Daiichi Sankyo Company Company Summary
Table 47. Daiichi Sankyo Company Influenza Medication Product Offerings
Table 48. Daiichi Sankyo Company Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Daiichi Sankyo Company Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Influenza Medication Product Offerings
Table 52. GlaxoSmithKline Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Natco Pharma Company Summary
Table 55. Natco Pharma Influenza Medication Product Offerings
Table 56. Natco Pharma Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Natco Pharma Key News & Latest Developments
Table 58. F. Hoffmann-La Roche Company Summary
Table 59. F. Hoffmann-La Roche Influenza Medication Product Offerings
Table 60. F. Hoffmann-La Roche Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. F. Hoffmann-La Roche Key News & Latest Developments
Table 62. Teva Pharmaceutical Company Summary
Table 63. Teva Pharmaceutical Influenza Medication Product Offerings
Table 64. Teva Pharmaceutical Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Teva Pharmaceutical Key News & Latest Developments
Table 66. Sandoz International Company Summary
Table 67. Sandoz International Influenza Medication Product Offerings
Table 68. Sandoz International Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Sandoz International Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Company Summary
Table 71. Sun Pharmaceutical Industries Influenza Medication Product Offerings
Table 72. Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Sun Pharmaceutical Industries Key News & Latest Developments
Table 74. Mylan Company Summary
Table 75. Mylan Influenza Medication Product Offerings
Table 76. Mylan Influenza Medication Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Mylan Key News & Latest Developments
Table 78. Influenza Medication Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 79. Global Influenza Medication Capacity Market Share of Key Manufacturers, 2022-2024
Table 80. Global Influenza Medication Production by Region, 2019-2024 (K Units)
Table 81. Global Influenza Medication Production by Region, 2025-2030 (K Units)
Table 82. Influenza Medication Market Opportunities & Trends in Global Market
Table 83. Influenza Medication Market Drivers in Global Market
Table 84. Influenza Medication Market Restraints in Global Market
Table 85. Influenza Medication Raw Materials
Table 86. Influenza Medication Raw Materials Suppliers in Global Market
Table 87. Typical Influenza Medication Downstream
Table 88. Influenza Medication Downstream Clients in Global Market
Table 89. Influenza Medication Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Influenza Medication Segment by Type in 2023
Figure 2. Influenza Medication Segment by Application in 2023
Figure 3. Global Influenza Medication Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Influenza Medication Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Influenza Medication Revenue, 2019-2030 (US$, Mn)
Figure 7. Influenza Medication Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Medication Revenue in 2023
Figure 9. By Type - Global Influenza Medication Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Influenza Medication Revenue Market Share, 2019-2030
Figure 11. By Type - Global Influenza Medication Sales Market Share, 2019-2030
Figure 12. By Type - Global Influenza Medication Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Influenza Medication Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Influenza Medication Revenue Market Share, 2019-2030
Figure 15. By Application - Global Influenza Medication Sales Market Share, 2019-2030
Figure 16. By Application - Global Influenza Medication Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Influenza Medication Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Influenza Medication Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Influenza Medication Revenue Market Share, 2019-2030
Figure 20. By Region - Global Influenza Medication Sales Market Share, 2019-2030
Figure 21. By Country - North America Influenza Medication Revenue Market Share, 2019-2030
Figure 22. By Country - North America Influenza Medication Sales Market Share, 2019-2030
Figure 23. US Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Influenza Medication Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Influenza Medication Sales Market Share, 2019-2030
Figure 28. Germany Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 29. France Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Influenza Medication Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Influenza Medication Sales Market Share, 2019-2030
Figure 37. China Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 41. India Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Influenza Medication Revenue Market Share, 2019-2030
Figure 43. By Country - South America Influenza Medication Sales Market Share, 2019-2030
Figure 44. Brazil Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Influenza Medication Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Influenza Medication Sales Market Share, 2019-2030
Figure 48. Turkey Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Influenza Medication Revenue, (US$, Mn), 2019-2030
Figure 52. Global Influenza Medication Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Influenza Medication by Region, 2023 VS 2030
Figure 54. Influenza Medication Industry Value Chain
Figure 55. Marketing Channels